Hawkins, Inc. (NASDAQ:HWKN – Get Free Report) has been assigned a consensus rating of “Moderate Buy” from the five research firms that are presently covering the company, MarketBeat reports. Two investment analysts have rated the stock with a hold recommendation and three have given a buy recommendation to the company. The average 12-month target price among brokers that have covered the stock in the last year is $162.50.
Several research analysts recently weighed in on HWKN shares. Zacks Research raised shares of Hawkins from a “strong sell” rating to a “hold” rating in a report on Friday, January 2nd. BWS Financial restated a “buy” rating and issued a $200.00 price objective on shares of Hawkins in a research report on Monday, November 3rd. Finally, Weiss Ratings reiterated a “buy (b-)” rating on shares of Hawkins in a research report on Monday, December 29th.
Get Our Latest Research Report on Hawkins
Insider Buying and Selling at Hawkins
Institutional Inflows and Outflows
Several hedge funds and other institutional investors have recently made changes to their positions in HWKN. Salomon & Ludwin LLC purchased a new position in Hawkins during the third quarter worth approximately $27,000. BNP PARIBAS ASSET MANAGEMENT Holding S.A. purchased a new stake in Hawkins in the 2nd quarter valued at $31,000. First Horizon Corp acquired a new stake in shares of Hawkins in the 3rd quarter worth $34,000. Aster Capital Management DIFC Ltd raised its holdings in shares of Hawkins by 62.2% during the 3rd quarter. Aster Capital Management DIFC Ltd now owns 300 shares of the specialty chemicals company’s stock worth $55,000 after acquiring an additional 115 shares during the period. Finally, Parkside Financial Bank & Trust boosted its position in shares of Hawkins by 694.1% during the 3rd quarter. Parkside Financial Bank & Trust now owns 405 shares of the specialty chemicals company’s stock valued at $74,000 after acquiring an additional 354 shares during the last quarter. Institutional investors own 69.71% of the company’s stock.
Hawkins Trading Up 2.6%
Hawkins stock opened at $157.66 on Friday. The firm has a 50 day moving average of $137.42 and a 200 day moving average of $156.15. The firm has a market capitalization of $3.29 billion, a price-to-earnings ratio of 39.61, a P/E/G ratio of 2.44 and a beta of 0.86. Hawkins has a 12-month low of $98.30 and a 12-month high of $186.15. The company has a current ratio of 2.43, a quick ratio of 1.49 and a debt-to-equity ratio of 0.53.
Hawkins (NASDAQ:HWKN – Get Free Report) last issued its quarterly earnings results on Wednesday, October 29th. The specialty chemicals company reported $1.08 earnings per share for the quarter, missing the consensus estimate of $1.24 by ($0.16). The firm had revenue of $280.43 million for the quarter, compared to analysts’ expectations of $284.42 million. Hawkins had a net margin of 7.95% and a return on equity of 17.42%. As a group, research analysts predict that Hawkins will post 4 earnings per share for the current year.
Hawkins Announces Dividend
The business also recently disclosed a quarterly dividend, which was paid on Friday, November 28th. Stockholders of record on Friday, November 14th were given a dividend of $0.19 per share. The ex-dividend date was Friday, November 14th. This represents a $0.76 annualized dividend and a dividend yield of 0.5%. Hawkins’s dividend payout ratio (DPR) is presently 19.10%.
Hawkins Company Profile
Hawkins, Inc (NASDAQ: HWKN) is a specialty chemical company that produces and distributes water-treatment and industrial chemicals across North America. Founded in 1938 and headquartered in Roseville, Minnesota, the company has built a network of manufacturing facilities and distribution centers that serve municipal, industrial and commercial customers. As a publicly traded entity, Hawkins leverages its long-standing presence in the chemical distribution industry to provide tailored solutions for complex water-treatment challenges and specialty chemical needs.
Hawkins’ product portfolio encompasses a wide range of chemicals, including sodium hypochlorite, sodium hydroxide, hydrogen peroxide, chlorine, acids and specialty blends.
Read More
- Five stocks we like better than Hawkins
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- A U.S. “birthright” claim worth trillions – activated quietly
- Ticker Revealed: Pre-IPO Access to “Next Elon Musk” Company
- First Time Since 2007: All Warnings Active
- How the Rich Retire
Receive News & Ratings for Hawkins Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hawkins and related companies with MarketBeat.com's FREE daily email newsletter.
